Site icon OncologyTube

ASH 2015: Clinical Efficacy of Daratumumab Monotherapy in Patients with Heavily Pretreated RRMM

Dr. Saad Usmani reports on the clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma.

Exit mobile version